SCHAUMBURG, Ill.--(BUSINESS WIRE)--#PIPL--China’s Personal Information Protection Law (PIPL) recently went into effect, with potential consequences for enterprises around the world....
In Partnership with Japan Cloud, New Entity Supports Rapid Regional Growth TOKYO & SAN FRANCISCO--(BUSINESS WIRE)--PagerDuty (NYSE:PD), a leader in...
Establishing Standards for Experimental Assays and Bioinformatics Protocols Aim at Accelerating Development and Availability of New Cell and Gene Therapies...
Microcontroller Leader to Showcase Performance, High Integration and Security Advances at Embedded World 2022 Exhibition and Conference TOKYO--(BUSINESS WIRE)--#ArmCortexM85--Renesas Electronics...
Select Apple Store locations across the globe will host all-new Creative Studios sessions open to the local community CUPERTINO, Calif.--(BUSINESS...
Semperis experiencing hyper-growth attributed to its solutions' unique capability to defend and recover from directory-based attacks combined with the company's...
BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--#abreva--Cosette Pharmaceuticals, Inc ("Cosette"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic...
HONG KONG SAR - Media OutReach - 24 May 2022 - “Scaling Hong Kong to the Nordics”, co-organised by Cyberport...
Presentation will take place on Wednesday, June 8 at 2:30 PT PETAH TIKVA, Israel, May 24, 2022 (GLOBE NEWSWIRE) --...
Digital Finance Leader MoneyLion Expands Enterprise Data and Technology Capabilities with AEON Group, One of Asia’s Largest Retailers and Financial...
FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural...
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Dairy Flavors Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Flavor Profile, Form,...
DUBLIN--(BUSINESS WIRE)--The "India Construction Market Size, Trends and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and...
The confirmatory clinical, safety and efficacy study for AVT04, biosimilar candidate to Stelara® (ustekinumab) met its primary endpoint AVT04 (ustekinumab)...
Industrial Assets and Development Sites to Be Sought-After East Rail Line Extension to Drive Future Capital Appreciation in Adjacent Districts...
